Females with heterozygous COL4A5 variants are not only asymptomatic carriers of X-linked Alport syndrome but also face an increased risk of CKD, early- or late-onset ESRD, and extrarenal manifestations. The gene discussed is COL4A5; the disease is chronic kidney disease.